These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 2284101

  • 21. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
    Schwab M.
    Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
    [Abstract] [Full Text] [Related]

  • 22. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS, Shay JW.
    Cancer Res; 1989 Aug 15; 49(16):4417-22. PubMed ID: 2568170
    [Abstract] [Full Text] [Related]

  • 23. Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma.
    Tonini GP, Verdona G, Garaventa A, Cornaglia-Ferraris P.
    Anticancer Res; 1987 Aug 15; 7(4B):729-32. PubMed ID: 3314672
    [Abstract] [Full Text] [Related]

  • 24. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
    Melegh Z, Bálint I, Tóth E, Csernák E, Szentirmay Z, Nagy K.
    Pediatr Pathol Mol Med; 2003 Aug 15; 22(3):213-22. PubMed ID: 12746172
    [Abstract] [Full Text] [Related]

  • 25. myc gene amplification and expression in primary human neuroblastoma.
    Slavc I, Ellenbogen R, Jung WH, Vawter GF, Kretschmar C, Grier H, Korf BR.
    Cancer Res; 1990 Mar 01; 50(5):1459-63. PubMed ID: 2302711
    [Abstract] [Full Text] [Related]

  • 26. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W, Schwab M.
    Oncogene; 1997 Jul 17; 15(3):303-15. PubMed ID: 9233765
    [Abstract] [Full Text] [Related]

  • 27. [Tumor cytogenetics and prognosis in neuroblastoma].
    Christiansen H, Lampert F.
    Monatsschr Kinderheilkd; 1989 Oct 17; 137(10):666-71. PubMed ID: 2586532
    [Abstract] [Full Text] [Related]

  • 28. High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Sharon B, Kennett RH, Rosen ST.
    Prog Clin Biol Res; 1991 Oct 17; 366():21-7. PubMed ID: 2068139
    [No Abstract] [Full Text] [Related]

  • 29. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
    Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D.
    Cancer Res; 1991 Dec 15; 51(24):6529-38. PubMed ID: 1742726
    [Abstract] [Full Text] [Related]

  • 30. Human neuroblastoma cell lines that express N-myc without gene amplification.
    Wada RK, Seeger RC, Brodeur GM, Einhorn PA, Rayner SA, Tomayko MM, Reynolds CP.
    Cancer; 1993 Dec 01; 72(11):3346-54. PubMed ID: 8242562
    [Abstract] [Full Text] [Related]

  • 31. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T, Scott D, Takamizawa S, Wen J, Davidoff A, Fukuzawa M, Sandler A.
    J Pediatr Surg; 2001 Dec 01; 36(12):1785-91. PubMed ID: 11733907
    [Abstract] [Full Text] [Related]

  • 32. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
    Wittrock J, Schweizer P, Girgert R.
    Anticancer Res; 2002 Dec 01; 22(6C):4205-9. PubMed ID: 12553057
    [Abstract] [Full Text] [Related]

  • 33. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry.
    Gazitt Y, He YJ, Chang L, Koza S, Fisk D, Graham-Pole J.
    Cancer Res; 1992 May 15; 52(10):2957-65. PubMed ID: 1374683
    [Abstract] [Full Text] [Related]

  • 34. The biological effects of antisense N-myc expression in human neuroblastoma.
    Schmidt ML, Salwen HR, Manohar CF, Ikegaki N, Cohn SL.
    Cell Growth Differ; 1994 Feb 15; 5(2):171-8. PubMed ID: 8180130
    [Abstract] [Full Text] [Related]

  • 35. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
    Oberthuer A, Skowron M, Spitz R, Kahlert Y, Westermann F, Mehler K, Berthold F, Fischer M.
    Gene; 2005 Dec 19; 363():41-50. PubMed ID: 16216448
    [Abstract] [Full Text] [Related]

  • 36. Multiple amplicons of discrete sizes encompassing N-myc in neuroblastoma cells evolve through differential recombination from a large precursor DNA.
    Amler LC, Schwab M.
    Oncogene; 1992 Apr 19; 7(4):807-9. PubMed ID: 1565478
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L, Iyer J, Zhu S, Frick KK, Wada RK, Eskenazi AE, Berg PE, Ikegaki N, Kennett RH, Frantz CN.
    Cancer Res; 2001 Feb 01; 61(3):1073-9. PubMed ID: 11221835
    [Abstract] [Full Text] [Related]

  • 38. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
    Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP.
    Clin Cancer Res; 2000 May 01; 6(5):1900-8. PubMed ID: 10815914
    [Abstract] [Full Text] [Related]

  • 39. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
    George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J.
    Oncogene; 1996 Apr 04; 12(7):1583-7. PubMed ID: 8622876
    [Abstract] [Full Text] [Related]

  • 40. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E, Da Silva J, Riou G, Bénard I.
    Cancer Res; 1994 Apr 15; 54(8):2256-61. PubMed ID: 8174136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.